INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 296
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Telacure

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Provider-guided peptide & longevity telehealth.' 'Healthspan by design, not by guesswork.' 'Built around you, not a product.'

Audienceread

US consumers seeking provider-supervised peptide protocols for recovery, longevity, body composition or metabolic health.

Pricing & termsverified

Peptide Therapy Membership $199/month, cancel anytime; membership fee covers care and fulfillment coordination.

Clinical relationshipspartial

'Provider-guided peptide & longevity telehealth.' Licensed clinician evaluation and protocol design, ongoing dose adjustments and side-effect review, secure messaging with care team.

Pharmacy & fulfillmentpartial

Compounded by FDA-registered pharmacies; shipped monthly.

Advertising snapshotpartial

Google: No ads found for telacure.com (US, last 30 days, 20 Oct 2026). Meta: Meta Ad Library keyword lookup returned no matching ads on 20 Oct 2026. LinkedIn: No results found in LinkedIn Ad Library on 20 Oct 2026.

Founding yearnot_found

Not established in this pass.

    Foundersnot_found

    Not established in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.